{"id":24637,"date":"2020-01-28T21:42:03","date_gmt":"2020-01-28T20:42:03","guid":{"rendered":"https:\/\/www.icscyl.com\/mileon\/?p=24637"},"modified":"2020-02-01T18:22:47","modified_gmt":"2020-02-01T17:22:47","slug":"ocrelizumab-en-em-sobre-un-afecto-adverso-letal","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/maitines\/2020-01-28\/ocrelizumab-en-em-sobre-un-afecto-adverso-letal\/","title":{"rendered":"Ocrelizumab en EM. Sobre un afecto adverso letal."},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"alignright size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2020\/01\/Imagen1-6.jpg\" alt=\"\" class=\"wp-image-24638\" width=\"318\" height=\"119\" srcset=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2020\/01\/Imagen1-6.jpg 878w, https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2020\/01\/Imagen1-6-300x113.jpg 300w, https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2020\/01\/Imagen1-6-768x290.jpg 768w, https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2020\/01\/Imagen1-6-624x235.jpg 624w\" sizes=\"auto, (max-width: 318px) 100vw, 318px\" \/><\/figure><\/div>\n\n\n\n<p>La Sesi\u00f3n de este martes 28 de Enero se plante\u00f3 como un caso cl\u00ednico a debate. El Dr. Luis Hern\u00e1ndez, neur\u00f3logo de nuestro Hospital, revisa el caso de un pacientte diagnosticado de EM con segumiento en su Servicio. En la segunda infusi\u00f3n de este f\u00e1rmaco sufre una PCR de la que sale, ingresa en UCI donde sufre una segunda parada en asistolia, y fallece. En la necropsia se iinforma de una severa pancarditis reum\u00e1tica. El ponente hace una amplia revisi\u00f3n de la historia cl\u00ednica del paciente,  de las indicaciones del este f\u00e1rmaco y de sus caracter\u00edsticas, de su utilidad en la EM y de sus posibles efectos secundarios. Se hace tambi\u00e9n una actualizaci\u00f3n de las infecciones por estreptococos y de la fiebre reum\u00e1tica. Para acabar, se plantean los principales interrogantes del caso: \u00bfqu\u00e9 le pas\u00f3 a este paciente?<\/p>\n\n\n\n<div class=\"wp-block-file\"><a href=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2020\/01\/Ocrelizumab-en-EM.pdf\">Ocrelizumab-en-EM<\/a><a href=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2020\/01\/Ocrelizumab-en-EM.pdf\" class=\"wp-block-file__button\" download>Descarga<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Sesi\u00f3n de este martes 28 de Enero se plante\u00f3 como un caso cl\u00ednico a debate. El Dr. Luis Hern\u00e1ndez, neur\u00f3logo de nuestro Hospital, revisa el caso de un pacientte diagnosticado de EM con segumiento en su Servicio. En la segunda infusi\u00f3n de este f\u00e1rmaco sufre una PCR de la que sale, ingresa en UCI [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[715],"tags":[866],"class_list":["post-24637","post","type-post","status-publish","format-standard","hentry","category-maitines","tag-hernandez"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/24637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=24637"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/24637\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=24637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=24637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=24637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}